| pubmed-article:20097702 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20097702 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20097702 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:20097702 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20097702 | lifeskim:mentions | umls-concept:C2713495 | lld:lifeskim |
| pubmed-article:20097702 | lifeskim:mentions | umls-concept:C0916168 | lld:lifeskim |
| pubmed-article:20097702 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20097702 | pubmed:dateCreated | 2010-2-15 | lld:pubmed |
| pubmed-article:20097702 | pubmed:abstractText | Co-primary objectives were to evaluate dalcetrapib (JTT-705/RO4607381), which targets cholesteryl ester transfer protein (CETP), effects on high-density lipoprotein cholesterol (HDL-C) in participants with coronary heart disease or risk equivalents and to evaluate potential changes in mesenteric lymph nodes. | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20097702 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20097702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20097702 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20097702 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:20097702 | pubmed:issn | 1522-9645 | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:SteinEvan AEA | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:RobinsonJenni... | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:KallendDavidD | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:RothEli MEM | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:BurgessTracyT | lld:pubmed |
| pubmed-article:20097702 | pubmed:author | pubmed-author:RhyneJames... | lld:pubmed |
| pubmed-article:20097702 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20097702 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:20097702 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20097702 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20097702 | pubmed:pagination | 480-8 | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:meshHeading | pubmed-meshheading:20097702... | lld:pubmed |
| pubmed-article:20097702 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20097702 | pubmed:articleTitle | Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial. | lld:pubmed |
| pubmed-article:20097702 | pubmed:affiliation | Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. esteinmrl@aol.com | lld:pubmed |
| pubmed-article:20097702 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20097702 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20097702 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20097702 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20097702 | lld:pubmed |
